Framatome and Romanian nuclear utility SN Nuclearelectrica (SNN) have signed a long-term cooperation agreement to produce ...

Nuclearelectrica (BVB: SNN) and France's Framatome have signed an agreement to produce the medical isotope Lutetium-177 ...

AN Irish dad with terminal cancer has called on the Government to fund lifesaving cancer treatments instead of expensive bike ...

SNN], the operator of Romania's sole nuclear power plant (NPP) Cernavoda, said on Thursday that its net profit dropped 35% ...

Metastatic castration-resistant prostate cancer (mCRPC) is a severe form of late-stage disease where the tumor can no longer ...

These include actinium-225, which is typically used for targeted cancer therapies, strontium-89 for bone cancer pain relief, ...

This innovation enables the transformation of both small- and large-molecule ligand-targeted drugs into dual-purpose agents, ...

The hot cell at Bruce Power will support the initial processing of lutetium-177 that involves removing the aluminum carriers ...

Ontario’s Minister of Energy and Electrification visited Bruce Power on Friday to help announce the expansion of the nuclear ...

Scott Burgess explains why members who respond to a radiological incident can't overlook the limitations of radiological monitors.

In contrast, beta emitters such as lutetium-177 (177 Lu) and iodine-131 (131 I) have a longer penetration, which may suit bulky metastatic disease. The development of TATs is a priority research and ...

Q3 2024 Earnings Call Transcript November 8, 2024 Y-mAbs Therapeutics, Inc. reports earnings inline with expectations.